Increasing Provision of Type 1 Diabetes Care
A Call to Action for Children and Young People in Mali
The Challenge of Type 1 Diabetes
Type 1 diabetes (T1D), an autoimmune disorder, is typically diagnosed in young people. Daily insulin injections are required for survival. People with T1D need access to insulin, home blood glucose monitoring, diabetes education & skilled medical care.
Many under-resourced health systems cannot provide sufficient access to these essential medications and tools.
People with T1D face severe risks of dying quickly, remaining chronically unwell, or developing devastating complications without access to these.
Currently, T1D incidence in Mali is <25 years per 100,000 is 0.74*. T1D prevalence is 2.90 per 100,000*
The way forward is securing Universal Health Coverage
- The Malian Public Health System has made much progress in providing components of T1D care, yet the costs of these are not covered.
- People with T1D have to pay out of pocket for human insulin, syringes, lancets, blood glucose meters and test strips, HbA1c tests, and standard medical reviews.
- The Public Health System does not provide analogue insulin (modern insulin), retinopathy services, or dialysis.
- Private health insurance programs (AMO, RAMED) do cover a proportion of the costs for human insulin, blood glucose meters and test strips, syringes, HbA1c tests, and standard medical reviews, but only a small percentage of the population is covered under these.
- The majority of people with T1D have to pay out of pocket for their care, but too many cannot sustainably afford the medications and care they need to manage their chronic disease.
- All components of care need to be provided to young people with T1D at reasonable costs.